Dyne Therapeutics 40% Rally Faces Fund Selloff Questions
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Discover the smartest strategies for using a rewards credit card. Learn how to maximize benefits and save on your expenses.
27,792 articlesA dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
When a global pharma giant drops $1 billion on a single tech, investors sit up. This move by Johnson Johnson Just Pai...
A surge in triple-leveraged ETFs has driven notional exposure to about $500 billion, intensifying daily volatility an...
Healthcare costs loom large for retirees and investors alike. This article argues that one AI-driven healthcare leade...
Williams Projects a robust 2026 as U.S. natural gas output and LNG demand surge, underscoring the country’s energy se...
As Q2 2026 gains momentum, XRP, Solana, and BNB post modest climbs. Investors eye price thresholds and upcoming catal...
Nvidia CEO Jensen Huang spoke on AI’s societal impact and the politics surrounding it, highlighting how leadership, p...
A record quarterly wave of AI data-center disruption worth about $130 billion has sparked a fresh warning from Mark C...
XRP is gaining on-chain strength while price action remains muted, moving ahead of Solana in tokenized asset value an...
Billionaire investor Peter Thiel arrives in Rome for a private four-day series on the Antichrist, drawing sharp quest...
Two entertainment giants, Netflix and Disney, are navigating a fast-changing landscape. This analysis breaks down rec...
Small-cap stocks are staging a comeback. This article breaks down why this small-cap outperforming still matters, how...